Stem Cells and Osteoporosis Therapy

被引：86

作者：

Teitelbaum, Steven L. ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA

来源：

CELL STEM CELL | 2010年 / 7卷 / 05期

关键词：

PARATHYROID-HORMONE; ALENDRONATE;

D O I：

10.1016/j.stem.2010.10.004

中图分类号：

Q813 [细胞工程];

学科分类号：

100113 [医学细胞生物学];

摘要：

Skeletal remodeling requires recruitment of osteoblast precursors, in the form of MSCs, to the bone surface. In this issue of Cell Stem Cell, Wu et al. (2010) demonstrate that this event is mediated by osteoclastic mobilization of active transforming growth factor beta 1, which is inhibited by a common antiosteoporosis drug.

引用

收藏

页码：553 / 554

页数：2

相关论文

共 9 条

[1]

Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment [J].

Allen, Matthew R. ;

Burr, David B. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (11) :1759-1765

[2]

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis [J].

Black, DM ;

Bilezikian, JP ;

Ensrud, KE ;

Greenspan, SL ;

Palermo, L ;

Hue, T ;

Lang, TF ;

McGowan, JA ;

Rosen, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (06) :555-565

[3]

Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].

Bone, HG ;

Hosking, D ;

Devogelaer, J ;

Tucci, JR ;

Emkey, RD ;

Tonino, RP ;

Rodriguez-Portales, JA ;

Downs, RW ;

Gupta, J ;

Santora, AC ;

Liberman, UA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199

[4]

Bisphosphonates: Mechanism of action and role in clinical practice [J].

Drake, Mathew T. ;

Clarke, Bart L. ;

Khosla, Sundeep .

MAYO CLINIC PROCEEDINGS, 2008, 83 (09) :1032-1045

[5]

Odanacatib in the Treatment of Postmenopausal Women With Low Bone Mineral Density: Three-Year Continued Therapy and Resolution of Effect [J].

Eisman, John A. ;

Bone, Henry G. ;

Hosking, David J. ;

McClung, Michael R. ;

Reid, Ian R. ;

Rizzoli, Rene ;

Resch, Heinrich ;

Verbruggen, Nadia ;

Hustad, Carolyn M. ;

DaSilva, Carolyn ;

Petrovic, Romana ;

Santora, Arthur C. ;

Ince, B. Avery ;

Lombardi, Antonio .

JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (02) :242-251

[6]

Denosumab in postmenopausal women with low bone mineral density [J].

McClung, MR ;

Lewiecki, EM ;

Cohen, SB ;

Bolognese, MA ;

Woodson, GC ;

Moffett, AH ;

Peacock, M ;

Miller, PD ;

Lederman, SN ;

Chesnut, CH ;

Lain, D ;

Kivitz, AJ ;

Holloway, DL ;

Zhang, C ;

Peterson, MC ;

Bekker, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08) :821-831

[7]

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. [J].

Neer, RM ;

Arnaud, CD ;

Zanchetta, JR ;

Prince, R ;

Gaich, GA ;

Reginster, JY ;

Hodsman, AB ;

Eriksen, EF ;

Ish-Shalom, S ;

Genant, HK ;

Wang, OH ;

Mitlak, BH .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (19) :1434-1441

[8]

TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation [J].

Tang, Yi ;

Wu, Xiangwei ;

Lei, Weiqi ;

Pang, Lijuan ;

Wan, Chao ;

Shi, Zhenqi ;

Zhao, Ling ;

Nagy, Timothy R. ;

Peng, Xinyu ;

Hu, Junbo ;

Feng, Xu ;

Van Hul, Wim ;

Wan, Mei ;

Cao, Xu .

NATURE MEDICINE, 2009, 15 (07) :757-U9

[9]

Inhibition of Sca-1-Positive Skeletal Stem Cell Recruitment by Alendronate Blunts the Anabolic Effects of Parathyroid Hormone on Bone Remodeling [J].

Wu, Xiangwei ;

Pang, Lijuan ;

Lei, Weiqi ;

Lu, William ;

Li, Jun ;

Li, Zhaoyang ;

Frassica, Frank J. ;

Chen, Xueling ;

Wan, Mei ;

Cao, Xu .

CELL STEM CELL, 2010, 7 (05) :571-580